Mesa Laboratories, Inc. carries a market capitalization of 555.26M, placing it among publicly traded companies globally. Its enterprise value stands at 615.72M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 555.26M |
| Enterprise Value | 615.72M |
Mesa Laboratories, Inc. currently has 5.52M shares outstanding.
| Shares Outstanding | 5.52M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Mesa Laboratories, Inc. trades at a trailing price-to-earnings ratio of 72.63. The price-to-sales ratio is 1.96, and the price-to-book ratio stands at 2.57.
| PE Ratio | 72.63 |
| PS Ratio | 1.96 |
| PB Ratio | 2.57 |
| P/TBV Ratio | -5.81 |
| P/FCF Ratio | 10.65 |
| P/OCF Ratio | 11.38 |
On an enterprise value basis, Mesa Laboratories, Inc. trades at an EV/EBITDA multiple of 14.74 and an EV/FCF ratio of 11.83. The EV/Sales ratio of 2.47 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 33.26 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.47 |
| EV / EBITDA | 14.74 |
| EV / EBIT | 33.26 |
| EV / FCF | 11.83 |
Mesa Laboratories, Inc. maintains a current ratio of 1.72, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 83.31, indicating elevated leverage, while an interest coverage ratio of 3.91 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.72 |
| Quick Ratio | 1.15 |
| Debt / Equity | 83.31 |
| Debt / EBITDA | 3.71 |
| Interest Coverage | 3.91 |
Mesa Laboratories, Inc. posts a return on equity of 3.74 and a return on invested capital of 2.94.
| Return on Equity (ROE) | 3.74 |
| Return on Assets (ROA) | 1.56 |
| Return on Invested Capital (ROIC) | 2.94 |
| Return on Capital Employed (ROCE) | 3.65 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.51 |
Over the trailing twelve months, Mesa Laboratories, Inc. has paid 5.30M in income taxes, reflecting an effective tax rate of 44.13.
| Income Tax | 5.30M |
| Effective Tax Rate | 44.13 |
Mesa Laboratories, Inc.'s stock has gained approximately 34.6463% over the past 52 weeks. The 50-day moving average sits at 100.69, while the 200-day moving average is 88.44.
| Beta (5Y) | N/A |
| 52-Week Price Change | 34.6463% |
| 50-Day Moving Average | 100.69 |
| 200-Day Moving Average | 88.44 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Mesa Laboratories, Inc. generated 249.13M in revenue and converted that into 6.71M in net income, yielding earnings per share of 1.21. EBITDA reached 41.78M, while operating income came in at 18.51M.
| Revenue | 249.13M |
| Gross Profit | 158.27M |
| Operating Income | 18.51M |
| Pretax Income | 12.01M |
| Net Income | 6.71M |
| EBITDA | 41.78M |
| EBIT | 18.51M |
| Earnings Per Share (EPS) | 1.21 |
Mesa Laboratories, Inc. holds 26.93M in cash and equivalents against 155.17M in total debt, resulting in a net debt position of 124.55M. Total book value stands at 189.60M, with working capital of 44.37M providing operational flexibility.
| Cash & Cash Equivalents | 26.93M |
| Total Debt | 155.17M |
| Net Debt | 124.55M |
| Equity (Book Value) | 189.60M |
| Book Value Per Share | 34.39 |
| Working Capital | 44.37M |
Mesa Laboratories, Inc. produced 42.83M in operating cash flow over the past twelve months. After subtracting -3.25M in capital expenditures, free cash flow totaled 39.58M - equivalent to 7.18 per share.
| Operating Cash Flow | 42.83M |
| Capital Expenditures | -3.25M |
| Free Cash Flow | 39.58M |
| FCF Per Share | 7.18 |
Mesa Laboratories, Inc. operates with a gross margin of 63.53, reflecting its pricing power and cost economics. The operating margin of 7.43 and net profit margin of 2.69 provide insight into operational efficiency.
| Gross Margin | 63.53 |
| Operating Margin | 7.43 |
| Pretax Margin | 4.82 |
| Profit Margin | 2.69 |
| EBITDA Margin | 16.77 |
The company's payout ratio of 52.49 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.64 |
| Dividend Yield | N/A |
| Payout Ratio | 52.49 |
| Shareholder Yield | 8.59 |
| FCF Yield | 9.39 |
Mesa Laboratories, Inc. posts an Altman Z-Score of 1.87, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.87 |